Xinli Shi

994 total citations
50 papers, 767 citations indexed

About

Xinli Shi is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Xinli Shi has authored 50 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 17 papers in Cell Biology and 17 papers in Immunology. Recurrent topics in Xinli Shi's work include Hippo pathway signaling and YAP/TAZ (15 papers), Autophagy in Disease and Therapy (11 papers) and Ubiquitin and proteasome pathways (8 papers). Xinli Shi is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (15 papers), Autophagy in Disease and Therapy (11 papers) and Ubiquitin and proteasome pathways (8 papers). Xinli Shi collaborates with scholars based in China, Australia and Hong Kong. Xinli Shi's co-authors include Li Wang, Liyuan Hao, Jianchun Li, Qing Peng, Shenghao Li, Jingmin Ji, Shenghao Li, Nan Mao, Zhiqin Zhang and Yajing Sun and has published in prestigious journals such as The FASEB Journal, Frontiers in Immunology and Frontiers in Microbiology.

In The Last Decade

Xinli Shi

47 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinli Shi China 19 398 165 155 139 111 50 767
Huixiang Yang China 20 439 1.1× 124 0.8× 122 0.8× 104 0.7× 67 0.6× 71 1.0k
Feng Ren China 20 388 1.0× 141 0.9× 200 1.3× 104 0.7× 46 0.4× 43 917
Jia Zhou China 19 319 0.8× 187 1.1× 130 0.8× 88 0.6× 43 0.4× 61 921
Huaidong Hu China 17 418 1.1× 136 0.8× 125 0.8× 183 1.3× 64 0.6× 29 864
Zhiming Liu China 19 490 1.2× 175 1.1× 100 0.6× 135 1.0× 47 0.4× 50 923
Chang Geun Lee South Korea 18 285 0.7× 135 0.8× 152 1.0× 114 0.8× 48 0.4× 46 739
Munetaka Ozeki Japan 17 474 1.2× 85 0.5× 104 0.7× 74 0.5× 50 0.5× 39 897
Lihua Wu China 14 368 0.9× 164 1.0× 88 0.6× 165 1.2× 26 0.2× 62 855
David T. Coleman United States 15 284 0.7× 61 0.4× 106 0.7× 120 0.9× 101 0.9× 21 767

Countries citing papers authored by Xinli Shi

Since Specialization
Citations

This map shows the geographic impact of Xinli Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinli Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinli Shi more than expected).

Fields of papers citing papers by Xinli Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinli Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinli Shi. The network helps show where Xinli Shi may publish in the future.

Co-authorship network of co-authors of Xinli Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Xinli Shi. A scholar is included among the top collaborators of Xinli Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinli Shi. Xinli Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yuman, Jiali Yang, Yi Gong, et al.. (2025). RalB promotes lymph node metastasis in tongue squamous cell carcinoma. Genes & Genomics. 47(6). 697–705. 1 indexed citations
2.
Yang, Yanguang & Xinli Shi. (2025). Big lessons from the little Akkermansia muciniphila in hepatocellular carcinoma. Frontiers in Immunology. 16. 1524563–1524563. 2 indexed citations
3.
4.
5.
Gong, Yi, et al.. (2024). Lycium barbarum L. Balanced intestinal flora with YAP1/FXR activation in drug-induced liver injury. International Immunopharmacology. 130. 111762–111762. 13 indexed citations
6.
7.
Gong, Yi, Qing Peng, Yuting Gao, et al.. (2023). Dihydroartemisinin inhibited interleukin-18 expression by decreasing YAP1 in hepatocellular carcinoma cells. Acta Histochemica. 125(4). 152040–152040. 8 indexed citations
8.
Zhou, Wenhan, Jingmin Ji, Yiwei Liu, et al.. (2023). Si-Ni-San reduces lipid droplet deposition associated with decreased YAP1 in metabolic dysfunction–associated fatty liver disease. Journal of Ethnopharmacology. 305. 116081–116081. 11 indexed citations
9.
Ji, Jingmin, et al.. (2022). The Effects of Qinghao-Kushen and Its Active Compounds on the Biological Characteristics of Liver Cancer Cells. Evidence-based Complementary and Alternative Medicine. 2022. 1–19. 3 indexed citations
10.
Ji, Jingmin, Zhiqin Zhang, Hongyue Gao, et al.. (2022). Modulation of Oral Microflora during <em>Helicobacter Pylori </em>Eradication. Journal of College of Physicians And Surgeons Pakistan. 32(3). 308–312. 1 indexed citations
11.
Gao, Yuting, Yi Gong, Yiwei Liu, et al.. (2022). Integrated analysis of transcriptomics and metabolomics in human hepatocellular carcinoma HepG2215 cells after YAP1 knockdown. Acta Histochemica. 125(1). 151987–151987. 4 indexed citations
12.
Hao, Liyuan, Qing Peng, Zhiqin Zhang, et al.. (2021). Dihydroartemisinin reduced lipid droplet deposition by YAP1 to promote the anti-PD-1 effect in hepatocellular carcinoma. Phytomedicine. 96. 153913–153913. 27 indexed citations
13.
Li, Shenghao, Jingmin Ji, Zhiqin Zhang, et al.. (2020). Cisplatin promotes the expression level of PD-L1 in the microenvironment of hepatocellular carcinoma through YAP1. Molecular and Cellular Biochemistry. 475(1-2). 79–91. 36 indexed citations
14.
Shi, Xinli, Shenghao Li, Li Wang, et al.. (2020). RalB degradation by dihydroartemisinin induces autophagy and IFI16/caspase-1 inflammasome depression in the human laryngeal squamous cell carcinoma. Chinese Medicine. 15(1). 64–64. 19 indexed citations
15.
Shi, Xinli, et al.. (2017). Antitumor effect of dihydroartemisinin on hypopharyngeal cancer in nude mice with transplanted tumor.. Zhongliu fangzhi yanjiu. 44(10). 647–651. 3 indexed citations
16.
Shi, Xinli, Li Wang, Xiaoming Li, et al.. (2017). Dihydroartemisinin induces autophagy-dependent death in human tongue squamous cell carcinoma cells through DNA double-strand break-mediated oxidative stress. Oncotarget. 8(28). 45981–45993. 37 indexed citations
17.
Mao, Nan, Ruizhi Tan, Wei Cong, et al.. (2016). Ginsenoside Rg1 inhibits angiotensin II‐induced podocyte autophagy via AMPK/mTOR/PI3K pathway. Cell Biology International. 40(8). 917–925. 42 indexed citations
18.
Cui, Cheng, Helin Feng, Xinli Shi, et al.. (2015). Artesunate down-regulates immunosuppression from colorectal cancer Colon26 and RKO cells in vitro by decreasing transforming growth factor β1 and interleukin-10. International Immunopharmacology. 27(1). 110–121. 37 indexed citations
19.
Wu, Jinghua, Cuiqing Ma, Haixin Wang, et al.. (2014). A MyD88–JAK1–STAT1 complex directly induces SOCS-1 expression in macrophages infected with Group A Streptococcus. Cellular and Molecular Immunology. 12(3). 373–383. 18 indexed citations
20.
Shi, Xinli, Jingli Liu, Laifeng Ren, et al.. (2014). Nutlin-3 downregulates p53 phosphorylation on serine392and induces apoptosis in hepatocellular carcinoma cells. BMB Reports. 47(4). 221–226. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huixiang Yang Breakdown of academic impact, for papers by Feng Ren Breakdown of academic impact, for papers by Jia Zhou Breakdown of academic impact, for papers by Huaidong Hu Breakdown of academic impact, for papers by Zhiming Liu Breakdown of academic impact, for papers by Chang Geun Lee Breakdown of academic impact, for papers by Munetaka Ozeki Breakdown of academic impact, for papers by Lihua Wu Breakdown of academic impact, for papers by David T. Coleman
Rankless by CCL
2026